Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001601830-24-000115
Filing Date
2024-08-08
Accepted
2024-08-08 08:09:26
Documents
80
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rxrx-20240630.htm   iXBRL 10-Q 1053598
2 EX-10.1 exhibit101-crdoofferletter.htm EX-10.1 30621
3 EX-31.1 exhibit311-q0224.htm EX-31.1 7383
4 EX-31.2 exhibit312-q0224.htm EX-31.2 7370
5 EX-32.1 exhibit321-q0224.htm EX-32.1 3276
11 image_0.jpg GRAPHIC 13637
12 rxrx-20240630_g1.jpg GRAPHIC 97496
13 rxrx-20240630_g2.jpg GRAPHIC 209932
  Complete submission text file 0001601830-24-000115.txt   7381366

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rxrx-20240630.xsd EX-101.SCH 51351
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rxrx-20240630_cal.xml EX-101.CAL 92752
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rxrx-20240630_def.xml EX-101.DEF 259184
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rxrx-20240630_lab.xml EX-101.LAB 590170
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rxrx-20240630_pre.xml EX-101.PRE 420563
83 EXTRACTED XBRL INSTANCE DOCUMENT rxrx-20240630_htm.xml XML 908616
Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Filer) CIK: 0001601830 (see all company filings)

EIN.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40323 | Film No.: 241186182
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)